These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 27221825

  • 1. Impact of T cell activation, HIV replication and hepatitis C virus infection on neutrophil CD64 expression.
    Morquin D, Tuaillon E, Makinson A, Bendriss S, Le Moing V, Reynes J.
    Cytometry B Clin Cytom; 2017 Nov; 92(6):492-497. PubMed ID: 27221825
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapy-mediated immune responses in HCV/HIV-coinfected women: role of HCV on expression of primed/memory T cells.
    Al-Harthi L, Voris J, Du W, Wright D, Nowicki M, Frederick T, Landay A, Kovacs A.
    J Infect Dis; 2006 May 01; 193(9):1202-10. PubMed ID: 16586355
    [Abstract] [Full Text] [Related]

  • 4. HCV-specific T-cell responses in HIV/hepatitis C virus-coinfected patients on highly active antiretroviral therapy are comparable to those observed in hepatitis C virus-monoinfected individuals.
    Rallón NI, Soriano V, Restrepo C, García-Samaniego J, Labarga P, López M, Peris A, González-Lahoz J, Benito JM.
    J Acquir Immune Defic Syndr; 2011 May 01; 57(1):1-8. PubMed ID: 21786458
    [Abstract] [Full Text] [Related]

  • 5. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.
    d'Ettorre G, Ceccarelli G, Serafino S, Giustini N, Cavallari EN, Bianchi L, Pavone P, Bellelli V, Turriziani O, Antonelli G, Stroffolini T, Vullo V.
    J Med Virol; 2016 Aug 01; 88(8):1347-56. PubMed ID: 26765625
    [Abstract] [Full Text] [Related]

  • 6. Complementary role of HCV and HIV in T-cell activation and exhaustion in HIV/HCV coinfection.
    Feuth T, Arends JE, Fransen JH, Nanlohy NM, van Erpecum KJ, Siersema PD, Hoepelman AI, van Baarle D.
    PLoS One; 2013 Aug 01; 8(3):e59302. PubMed ID: 23555014
    [Abstract] [Full Text] [Related]

  • 7. [Causes of T lymphocyte activation in HIV-infected patients coinfected with hepatitis C virus].
    Shmagel KV, Shmagel NG, Korolevskaya LB, Saydakova EV, Chereshnev VA.
    Ter Arkh; 2016 Aug 01; 88(11):22-28. PubMed ID: 28005028
    [Abstract] [Full Text] [Related]

  • 8. Impact of hepatitis C viral replication on CD4+ T-lymphocyte progression in HIV-HCV coinfection before and after antiretroviral therapy.
    Potter M, Odueyungbo A, Yang H, Saeed S, Klein MB, Canadian Co-infection Cohort Study Investigators.
    AIDS; 2010 Jul 31; 24(12):1857-65. PubMed ID: 20479633
    [Abstract] [Full Text] [Related]

  • 9. Clinical Significance of Myeloid-Derived Suppressor Cells in Human Immunodeficiency Virus-1/ Hepatitis C Virus-coinfected Patients.
    Lei AH, Yang Q, Cai WP, Liu YF, Lan Y, Qin AP, Hu FY, Zhou J.
    Scand J Immunol; 2016 Jun 31; 83(6):438-44. PubMed ID: 26972443
    [Abstract] [Full Text] [Related]

  • 10. Human immunodeficiency virus type 1-hepatitis C virus coinfection: intraindividual comparison of cellular immune responses against two persistent viruses.
    Lauer GM, Nguyen TN, Day CL, Robbins GK, Flynn T, McGowan K, Rosenberg ES, Lucas M, Klenerman P, Chung RT, Walker BD.
    J Virol; 2002 Mar 31; 76(6):2817-26. PubMed ID: 11861849
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Impact of highly active antiretroviral treatment on expression of HIV-1 coreceptors and ligand levels in peripheral blood from HIV-1 infected patients in China.
    Fang J, Bai S, Wu L, Zhu X, Yao X, Jin C, Wang C.
    J Int Med Res; 2013 Oct 31; 41(5):1560-9. PubMed ID: 24043708
    [Abstract] [Full Text] [Related]

  • 13. HCV viraemia associates with NK cell activation and dysfunction in antiretroviral therapy-treated HIV/HCV-co-infected subjects.
    Papasavvas E, Azzoni L, Yin X, Liu Q, Joseph J, Mackiewicz A, Ross B, Lynn KM, Jacobson JM, Mounzer K, Kostman JR, Montaner LJ.
    J Viral Hepat; 2017 Oct 31; 24(10):865-876. PubMed ID: 28419653
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Impact of hepatitis C virus coinfection on immune restoration during successful antiretroviral therapy in chronic human immunodeficiency virus type 1 disease.
    Santin M, Mestre M, Shaw E, Barbera MJ, Casanova A, Niubo J, Bolao F, Podzamczer D, Gudiol F.
    Eur J Clin Microbiol Infect Dis; 2008 Jan 31; 27(1):65-73. PubMed ID: 17938979
    [Abstract] [Full Text] [Related]

  • 18. HCV Specific IL-21 Producing T Cells but Not IL-17A Producing T Cells Are Associated with HCV Viral Control in HIV/HCV Coinfection.
    MacParland SA, Fadel SM, Mihajlovic V, Fawaz A, Kim C, Rahman AK, Liu J, Kaul R, Kovacs C, Grebely J, Dore GJ, Wong DK, Ostrowski MA.
    PLoS One; 2016 Jan 31; 11(4):e0154433. PubMed ID: 27124305
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.